← Leaderboards
David Morgan
University Of South Florida
$15,699,395
Attributed
$21,302,180
Total exposure
10
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.4M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$21,302,180 · 10
By mechanism
R01$13,814,349 · 5
R44$3,469,823 · 1
R56$3,075,395 · 1
R41$392,663 · 1
R21$328,750 · 1
S10$221,200 · 1
Top collaborators
- James J Hickman6 shared
- Michael L Shuler3 shared
- Jerri Edwards2 shared
- Marcia N Gordon1 shared
- Xiufang Guo1 shared
- Alan P. Kozikowski1 shared
Most similar at University Of South Florida
Same institution · by research overlap
- David G Morgan$865,558
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposS DiseaseBrainDementiaClinical TrialsSuccessAmyloidBaseTauopathiesPhenotypePathologyDepositionMouse ModelPharmaceutical PreparationsResponseLeadTau ProteinsNeuronsInflammationTau AggregationCognitiveDoseAnimalsCost
Grant awards (41)
Investigating the role of Alzheimer's disease familial mutations in neuromuscular physiology$728,632
R01 · FY2025 · AG
Investigating the role of Alzheimer's disease familial mutations in neuromuscular physiology$743,502
R01 · FY2024 · AG
Investigating the role of Alzheimer's disease familial mutations in neuromuscular physiology$743,502
R01 · FY2023 · AG
Investigating the role of Alzheimer's disease familial mutations in neuromuscular physiology$764,558
R01 · FY2022 · AG
Functional integrated human-on-a-chip systems for Alzheimer's research$1,507,753
R44 · FY2020 · AG
Influence of systemic immune inflammation upon the tauopathy phenotype in mouse models$643,986
R01 · FY2020 · AG · contact PI
Functional integrated human-on-a-chip systems for Alzheimer's research$1,507,755
R44 · FY2019 · AG
Influence of systemic immune inflammation upon the tauopathy phenotype in mouse models$680,675
R01 · FY2019 · AG · contact PI
Preventing Alzheimer's Disease with Cognitive Training: The PACT Trial$373,750
R56 · FY2019 · AG
Preventing Alzheimer's Disease with Cognitive Training: The PACT Trial$2,701,645
R56 · FY2018 · AG
Influence of systemic immune inflammation upon the tauopathy phenotype in mouse models$708,239
R01 · FY2018 · AG · contact PI
Functional integrated human-on-a-chip systems for Alzheimer's research$454,315
R44 · FY2017 · AG
Influence of systemic immune inflammation upon the tauopathy phenotype in mouse models$418,235
R01 · FY2017 · AG · contact PI
Study of the New HDAC6i SW-100 as a Treatment for Alzheimerâs Disease and Other Tauopathies$392,663
R41 · FY2017 · AG
Influence of systemic immune inflammation upon the tauopathy phenotype in mouse models$314,315
R01 · FY2017 · AG · contact PI
Influence of systemic immune inflammation upon the tauopathy phenotype in mouse models$742,550
R01 · FY2016 · AG · contact PI
Immunotherapy against tauopathy in a transgenic mouse model$358,823
R01 · FY2015 · NS · contact PI
Immunotherapy against tauopathy in a transgenic mouse model$350,939
R01 · FY2014 · NS · contact PI
Immunotherapy against tauopathy in a transgenic mouse model$337,973
R01 · FY2013 · NS · contact PI
Immunotherapy against tauopathy in a transgenic mouse model$346,059
R01 · FY2012 · NS · contact PI
Immunotherapy against tauopathy in a transgenic mouse model$341,971
R01 · FY2011 · NS · contact PI
Functional Consequences of Vaccination in AD Tg Mice$272,569
R01 · FY2010 · AG · contact PI
AAV Gene Therapy for Alzheimer's Disease$389,208
R01 · FY2009 · AG · contact PI
Functional Consequences of Vaccination in AD Tg Mice$275,322
R01 · FY2009 · AG · contact PI
Digital Micscopic Image Scanning System$221,200
S10 · FY2009 · RR · contact PI
AAV Gene Therapy for Alzheimer's Disease$408,989
R01 · FY2008 · AG · contact PI
Functional Consequences of Vaccination in AD Tg Mice$275,322
R01 · FY2008 · AG · contact PI
AAV Gene Therapy for Alzheimer's Disease$405,129
R01 · FY2007 · AG · contact PI
Functional Consequences of Vaccination in AD Tg Mice$280,941
R01 · FY2007 · AG · contact PI
AAV Gene Therapy for Alzheimer's Disease$358,890
R01 · FY2006 · AG · contact PI
Functional Consequences of Vaccination in AD Tg Mice$289,331
R01 · FY2006 · AG · contact PI
AAV Gene Therapy for Alzheimer's Disease$30,760
R01 · FY2006 · AG · contact PI
AAV Gene Therapy for Alzheimer's Disease$368,024
R01 · FY2005 · AG
FUNCTIONAL CONSEQUENCES OF VACCINATION IN AD TG MICE$452,259
R01 · FY2004 · AG
FUNCTIONAL CONSEQUENCES OF VACCINATION IN AD TG MICE$449,645
R01 · FY2003 · AG
A vaccine approach to Parkinson's disease$158,750
R21 · FY2003 · NS
FUNCTIONAL CONSEQUENCES OF VACCINATION IN AD TG MICE$447,108
R01 · FY2002 · AG
A vaccine approach to Parkinson's disease$170,000
R21 · FY2002 · NS
FUNCTIONAL CONSEQUENCES OF VACCINATION IN AD TG MICE$444,643
R01 · FY2001 · AG
FUNCTIONAL CONSEQUENCES OF VACCINATION IN AD TG MICE$362,500
R01 · FY2000 · AG
FUNCTIOINAL CONSEQUENCES OF VACCINATION IN AD TG MICE$79,750
R01 · FY2000 · AG